BENZYL BENZOATE Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Benzyl Benzoate, and when can generic versions of Benzyl Benzoate launch?
Benzyl Benzoate is a drug marketed by Lannett and is included in one NDA.
The generic ingredient in BENZYL BENZOATE is benzyl benzoate. There are fifty drug master file entries for this compound. Additional details are available on the benzyl benzoate profile page.
AI Deep Research
Questions you can ask:
- What is the 5 year forecast for BENZYL BENZOATE?
- What are the global sales for BENZYL BENZOATE?
- What is Average Wholesale Price for BENZYL BENZOATE?
Summary for BENZYL BENZOATE
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Raw Ingredient (Bulk) Api Vendors: | 118 |
| Clinical Trials: | 6 |
| Patent Applications: | 2,310 |
| DailyMed Link: | BENZYL BENZOATE at DailyMed |
Recent Clinical Trials for BENZYL BENZOATE
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| College of Physicians and Surgeons Pakistan | EARLY_PHASE1 |
| University of Aleppo | PHASE3 |
| Tishreen University Hospital | PHASE3 |
Anatomical Therapeutic Chemical (ATC) Classes for BENZYL BENZOATE
US Patents and Regulatory Information for BENZYL BENZOATE
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Lannett | BENZYL BENZOATE | benzyl benzoate | EMULSION;TOPICAL | 084535-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
